Capital raised by Autonomy Bio
1 Form D filing · first filed Mar 2025 · San Francisco, CA
President
Signatory on Autonomy Bio's Form D filings · $17.0M raised across 1
Alex Colville is on file as President at Autonomy Bio in San Francisco, CA. Autonomy Bio has 1 Form D filing on record, $17.0M raised in total. Alex Colville appears as a signatory on the company's filings.
No other people are on file at Autonomy Bio. Form D filings only name the signatory and the company's executive officers.
EncRNA is a groundbreaking class of RNA therapeutics engineered for precision targeting of malignant cells, ensuring that therapeutic interventions activate specifically within cancer cells. This mechanism aims to enhance treatment efficacy while reducing the risk of toxicity associated with standard therapies.
